Cyclo Therapeutics, Inc. (CYTH) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Cyclo Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$5.12 M, a 2.28% decline year-over-year.
  • Cyclo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$20.2 M, a 14% decline year-over-year.
  • Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$20.1 M, a 28.3% decline from 2022.
  • Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$15.6 M, a 9.32% decline from 2021.
  • Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$14.3 M, a 59.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$20.2 M -$5.12 M -$114 K -2.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$20.1 M -$5.64 M -$660 K -13.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$19.4 M -$4.77 M -$519 K -12.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$18.9 M -$4.63 M -$1.18 M -34.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$17.7 M -$5.01 M -$2.07 M -70.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$15.6 M -$4.98 M -$2.19 M -78.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$13.4 M -$4.25 M -$389 K -10.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$13 M -$3.46 M +$144 K +4.01% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$13.2 M -$2.93 M +$1.1 M +27.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$14.3 M -$2.79 M -$112 K -4.17% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$14.2 M -$3.86 M -$2.42 M -169% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.8 M -$3.6 M -$1.4 M -63.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$10.4 M -$4.04 M -$1.4 M -52.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$8.96 M -$2.68 M -$43.6 K -1.65% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$8.92 M -$1.44 M +$193 K +11.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$9.11 M -$2.2 M -$832 K -60.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$8.28 M -$2.64 M -$734 K -38.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.54 M -$2.64 M -$1.27 M -92.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$6.27 M -$1.63 M -$839 K -106% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$5.44 M -$1.37 M -$75.5 K -5.84% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$5.36 M -$1.91 M -$1.09 M -134% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$4.27 M -$1.37 M +$17.1 K +1.24% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$4.28 M -$790 K -$153 K -24% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.13 M -$1.29 M -$464 K -55.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$3.67 M -$814 K +$176 K +17.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$3.84 M -$1.39 M -$590 K -74.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$3.25 M -$637 K +$974 K +60.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$4.23 M -$831 K +$237 K +22.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.46 M -$990 K -$257 K -35.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$4.21 M -$795 K +$137 K +14.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 -$4.34 M -$1.61 M -$871 K -118% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$3.47 M -$1.07 M -$715 K -203% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$2.76 M -$733 K -$351 K -91.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$2.41 M -$932 K -$622 K -201% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$1.79 M -$740 K -$543 K -274% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$1.24 M -$352 K -$139 K -65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$1.1 M -$383 K -$541 K -342% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$562 K -$310 K -$203 K -191% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$359 K -$198 K -$94.7 K -91.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$264 K -$213 K -$583 K -158% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $318 K $158 K -$18.3 K -10.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $337 K -$106 K -$276 K -163% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 $612 K -$103 K -$74.4 K -260% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $687 K $370 K +$429 K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $258 K $177 K +$100 K +131% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $157 K $169 K +$234 K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-04
Q3 2012 -$76 K -$28.6 K +$17.6 K +38% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$93.6 K -$59.3 K -$100 K -245% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $6.48 K $76.3 K +$80.7 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$74.3 K -$64.4 K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$46.2 K -$32.1 K -227% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $40.8 K +$15.3 K +60% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$4.43 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$14.1 K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-02-23
Q2 2010 $25.5 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.